2023 Q2 Form 10-Q Financial Statement

#000162828023014756 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q1
Revenue $466.7M $401.6M
YoY Change 11.82% 39.43%
Cost Of Revenue $322.3M $268.3M
YoY Change 16.81% 46.23%
Gross Profit $144.5M $133.2M
YoY Change 2.09% 27.5%
Gross Profit Margin 30.95% 33.18%
Selling, General & Admin $126.4M $86.53M
YoY Change 37.26% 37.56%
% of Gross Profit 87.46% 64.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.54M $9.743M
YoY Change 37.36% 33.47%
% of Gross Profit 9.37% 7.31%
Operating Expenses $126.4M $86.53M
YoY Change 37.26% 37.56%
Operating Profit $18.11M $46.71M
YoY Change -63.38% 12.29%
Interest Expense $11.95M $1.231M
YoY Change 663.77% 917.36%
% of Operating Profit 65.99% 2.64%
Other Income/Expense, Net $357.0K $84.00K
YoY Change 221.62% -1.18%
Pretax Income $6.518M $45.57M
YoY Change -86.42% 9.49%
Income Tax $835.0K $10.36M
% Of Pretax Income 12.81% 22.73%
Net Earnings $5.683M $35.21M
YoY Change -85.01% 7.57%
Net Earnings / Revenue 1.22% 8.77%
Basic Earnings Per Share $0.18 $1.12
Diluted Earnings Per Share $0.18 $1.11
COMMON SHARES
Basic Shares Outstanding 31.44M shares 31.50M
Diluted Shares Outstanding 31.54M shares 31.60M

Balance Sheet

Concept 2023 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.31M $53.43M
YoY Change -35.91% -67.93%
Cash & Equivalents $33.31M $53.43M
Short-Term Investments
Other Short-Term Assets $40.17M $13.51M
YoY Change 48.98% 37.83%
Inventory $686.9M $565.2M
Prepaid Expenses
Receivables $429.3M $456.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.190B $1.088B
YoY Change 5.19% 12.58%
LONG-TERM ASSETS
Property, Plant & Equipment $151.5M $116.2M
YoY Change 28.5% -10.8%
Goodwill $443.3M $198.1M
YoY Change 124.86%
Intangibles $317.0M $176.1M
YoY Change 83.6%
Long-Term Investments
YoY Change
Other Assets $50.50M $47.53M
YoY Change 10.32% -8.43%
Total Long-Term Assets $1.071B $636.1M
YoY Change 69.96% 113.67%
TOTAL ASSETS
Total Short-Term Assets $1.190B $1.088B
Total Long-Term Assets $1.071B $636.1M
Total Assets $2.261B $1.724B
YoY Change 28.36% 36.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $145.7M $165.8M
YoY Change -28.39% 39.95%
Accrued Expenses $233.3M $257.4M
YoY Change 2.53% 18.68%
Deferred Revenue
YoY Change
Short-Term Debt $215.5M $229.4M
YoY Change -6.06%
Long-Term Debt Due $12.50M
YoY Change
Total Short-Term Liabilities $606.9M $652.6M
YoY Change -8.09% 94.57%
LONG-TERM LIABILITIES
Long-Term Debt $479.4M $0.00
YoY Change
Other Long-Term Liabilities $16.75M $94.33M
YoY Change 227.32% 128.4%
Total Long-Term Liabilities $496.2M $94.33M
YoY Change 9596.85% 128.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $606.9M $652.6M
Total Long-Term Liabilities $496.2M $94.33M
Total Liabilities $1.103B $764.9M
YoY Change 65.77% 101.03%
SHAREHOLDERS EQUITY
Retained Earnings $961.6M
YoY Change 5.65%
Common Stock $90.73M
YoY Change 9.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.049B $959.4M
YoY Change
Total Liabilities & Shareholders Equity $2.261B $1.724B
YoY Change 28.36% 36.39%

Cashflow Statement

Concept 2023 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $5.683M $35.21M
YoY Change -85.01% 7.57%
Depreciation, Depletion And Amortization $13.54M $9.743M
YoY Change 37.36% 33.47%
Cash From Operating Activities $26.21M $23.21M
YoY Change 84.94% 10.44%
INVESTING ACTIVITIES
Capital Expenditures $10.54M $7.247M
YoY Change -219.02% 16.76%
Acquisitions -$267.0K -$595.0K
YoY Change
Other Investing Activities $267.0K $595.0K
YoY Change
Cash From Investing Activities -$10.27M -$6.652M
YoY Change 16.01% 7.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $3.125M $0.00
YoY Change
Cash From Financing Activities -$28.66M -21.96M
YoY Change 326.28% 480.11%
NET CHANGE
Cash From Operating Activities $26.21M 23.21M
Cash From Investing Activities -$10.27M -6.652M
Cash From Financing Activities -$28.66M -21.96M
Net Change In Cash -$12.73M -5.355M
YoY Change 805.84% -148.56%
FREE CASH FLOW
Cash From Operating Activities $26.21M $23.21M
Capital Expenditures $10.54M $7.247M
Free Cash Flow $15.67M $15.97M
YoY Change -31.93% 7.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-01
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
0-18914
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2078856
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3400 East Walnut Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Colmar
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18915
CY2023Q2 dei City Area Code
CityAreaCode
215
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
997-1800
CY2023Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2023Q2 dei Trading Symbol
TradingSymbol
DORM
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31468334 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466738000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
401579000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322261000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268339000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
144477000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
133240000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126363000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86528000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
18114000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
46712000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
11953000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1231000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
357000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6518000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45565000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
835000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10358000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5683000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1696000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5802000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36903000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31436000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31499000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31537000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31601000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33307000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46034000 usd
CY2023Q2 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1398000 usd
CY2022Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1363000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
429308000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
427385000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
686949000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
755901000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40173000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
39800000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1189737000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1269120000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
151541000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148477000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
108549000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
109977000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
443336000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
443035000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316999000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
322409000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50497000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48768000 usd
CY2023Q2 us-gaap Assets
Assets
2260659000 usd
CY2022Q4 us-gaap Assets
Assets
2341786000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
145686000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
179819000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14606000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19490000 usd
CY2023Q2 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
170432000 usd
CY2022Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
192116000 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
215460000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
239363000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
12500000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12500000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48239000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35007000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
606923000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
678295000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
479439000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
482464000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96571000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98221000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16749000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28349000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11833000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11826000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31469310 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31469310 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31430632 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31430632 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
315000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
314000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
90416000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
88750000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
961597000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
956870000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3184000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3303000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1049144000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1042631000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2260659000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2341786000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1042631000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1049000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2312000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
433000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-2217000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
119000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5683000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1049144000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932736000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2152000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
10917000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
377000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1851000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1696000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
959400000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5683000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35207000 usd
CY2023Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13540000 usd
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9743000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2744000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2334000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2152000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4673000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16727000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-68935000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33034000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
591000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
853000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2130000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1976000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-34258000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-12392000 usd
CY2023Q2 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
-21683000 usd
CY2022Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
7202000 usd
CY2023Q2 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
-3691000 usd
CY2022Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
409000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26210000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23214000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-267000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-595000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10537000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7247000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10270000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6652000 usd
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
23900000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3125000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1049000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q2 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
433000 usd
CY2022Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
10752000 usd
CY2023Q2 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-2254000 usd
CY2022Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-1211000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28663000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21963000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12727000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5355000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46034000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58782000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33307000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53427000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
11534000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
999000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1055000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
712000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
237700000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
275200000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
30839000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
34267000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
200491000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
234871000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
446544000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
478032000 usd
CY2023Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
9075000 usd
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
8731000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
686949000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
755901000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
443035000 usd
CY2023Q2 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
233000 usd
CY2023Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
68000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
443336000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
354517000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37518000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
316999000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
354517000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32108000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
322409000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5500000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
100000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
20500000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
500000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466738000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
401579000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466738000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
401579000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
238922 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
92.07
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
93944 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
98.02
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
59382 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
77.02
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8392 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
81.56
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
265092 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
97.88
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
400000 usd
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
400000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
268119 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
84.03
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
76784 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
91.28
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1113 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
96.36
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21702 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
72.85
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
322088 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
86.47
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1935000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
133913 shares
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
80.31
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1398000 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
237000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5683000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31436000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31499000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
101000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
102000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31537000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31601000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3400000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
2500000 usd

Files In Submission

Name View Source Status
0001628280-23-014756-index-headers.html Edgar Link pending
0001628280-23-014756-index.html Edgar Link pending
0001628280-23-014756.txt Edgar Link pending
0001628280-23-014756-xbrl.zip Edgar Link pending
dorm-20230401.htm Edgar Link pending
dorm-20230401.xsd Edgar Link pending
dorm-20230401x10qexx311.htm Edgar Link pending
dorm-20230401x10qexx312.htm Edgar Link pending
dorm-20230401x10qexx32.htm Edgar Link pending
dorm-20230401_g1.jpg Edgar Link pending
dormanproductsinc-amendeda.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
dorm-20230401_def.xml Edgar Link unprocessable
dorm-20230401_cal.xml Edgar Link unprocessable
dorm-20230401_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dorm-20230401_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dorm-20230401_pre.xml Edgar Link unprocessable